Inspire(US:INSP) Newsfileยท2025-11-12 21:32Core Insights - Faruqi & Faruqi, LLP is investigating potential claims against Inspire Medical Systems, Inc. regarding alleged violations of federal securities laws related to misleading statements about the Inspire V device launch [3][6] - Investors who suffered losses from August 6, 2024, to August 4, 2025, are encouraged to contact the firm to discuss their legal options before the January 5, 2026, deadline for seeking lead plaintiff status in a federal securities class action [2][3] Company Performance - Inspire Medical announced significant setbacks in the launch of its Inspire V device on August 4, 2025, citing delays due to incomplete training and onboarding at treatment centers [7] - The company faced billing and reimbursement challenges, with necessary software updates for claims processing not effective until July 1, 2025, leading to continued use of the older Inspire IV system [7] - Demand for the Inspire V device was reported as weak, resulting in excess inventory and a drastic cut in 2025 earnings guidance by over 80% [8] Market Impact - Following the announcement of these issues, Inspire Medical's stock price plummeted by more than 32%, from $129.95 per share on August 4, 2025, to $87.91 per share on August 5, 2025, erasing approximately $1.2 billion in market capitalization [8]